Targeted Drugs for Multiple Sclerosis Market Growth Outlook Showing...

добавлена новая статья Другое

2026-03-23 11:07:36 -

Targeted Drugs for Multiple Sclerosis Market Growth Outlook Showing 4.7% CAGR Through 2034

According to a new report from Intel Market Research, the global Targeted Drugs for Multiple Sclerosis market was valued at USD 27.5 billion in 2025 and is projected to reach USD 42.3 billion by 2034, growing at a CAGR of 4.7% during the forecast period (2026–2034). This growth is driven by the increasing global prevalence of multiple sclerosis, advancements in precision medicine, and the...

0 Комментарии 0 Поделились 35 Просмотры